Mometasone Sandoz (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Sandoz, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, seasonal and perennial forms, and nasal polyps by reducing inflammation in the nasal passages of adults and children, and is indicated for both adult and pediatric patients under medical supervision.

GNH USA supplies Mometasone Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on reliable quality, regulatory compliance and timely global distribution.

Mometasone furoate nasal spray is used to manage inflammatory conditions of the nasal passages.

Allergic rhinitis: reduces nasal congestion, itching and sneezing associated with seasonal allergies. Seasonal allergic rhinitis: provides relief of symptoms triggered by pollen exposure. Perennial allergic rhinitis: controls year‑round nasal inflammation caused by indoor allergens. Nasal polyps: helps shrink nasal polyps and improve nasal airflow.

Adverse reactions to Mometasone furoate nasal spray are generally mild but can vary in frequency and severity.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Headache: occasional mild headache. - Epistaxis: nosebleeds. - Throat irritation: dryness or soreness. - Cough: transient cough.

Serious or Rare Side Effects: - Nasal septal perforation: rare tissue damage. - Vision changes: blurred vision or cataracts. - Adrenal suppression: systemic glucocorticoid effect. - Severe allergic reaction: anaphylaxis or angioedema.

Before prescribing Mometasone furoate nasal spray, clinicians should consider several safety precautions. - Assess infection: avoid use in active nasal or sinus infections without medical supervision. - Monitor children: use the lowest effective dose in pediatric patients. - Evaluate surgery: discontinue before nasal or sinus surgery to reduce bleeding risk. - Systemic exposure: limit duration to avoid potential adrenal suppression. - Pregnancy and lactation: use only if the benefit outweighs potential risk. - Store at room temperature: keep below 25 °C, protect from moisture and direct sunlight.

Mometasone furoate nasal spray may interact with other medications that affect corticosteroid metabolism or increase bleeding risk.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use can increase risk of systemic glucocorticoid effects. - Antifungal azoles (ketoconazole, itraconazole): may raise systemic exposure.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): possible increased bleeding tendency. - Nasal decongestants: may cause additive nasal irritation. - CYP3A4 inducers (rifampin, phenytoin): may reduce local efficacy.